Mesoblast Limited vs NIO Inc. — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while NIO Inc. trades at $4.57 (market cap $11.59B). The key difference: NIO Inc. is far larger — about 5.2× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| MESO | NIO | |
|---|---|---|
Market Cap | $2.21B | $11.59B |
Sector | Technology | Consumer Cyclical |
52-Week High | $20.96 | $7.89 |
52-Week Low | $12.88 | $4.44 |
Enterprise Value | $2.21B | $10.82B |
Trailing returns across standard periods
Latest headlines on both assets
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →